Recently, The Doctors Company Foundation sponsored the University of Michigan’s Enhanced Diagnostic Reasoning (eDRx) project, addressing the need to boost trainees’ skills by employing a unique combination of ambient and artificial intelligence (AAI).
The team—lead by Prashant Mahajan, MD, MPH, MBA—has developed a completely new and innovative framework that can align all symptoms and signs using artificial intelligence and machine learning techniques, such as neural networks. The team continues to develop emergency medicine educational content and collaborate with educators and diagnosticians as it works to integrate and assess eDRx by testing resident user experience in a simulated setting.
The project’s long-term goal is to enhance and assess diagnostic reasoning, reduce diagnostic errors, and improve patient safety through development of an AAI system. Learn more about how the Foundation supports research projects that improve patient care.
The Doctor’s Advocate is published by The Doctors Company to advise and inform its members about loss prevention and insurance issues.
The guidelines suggested in this newsletter are not rules, do not constitute legal advice, and do not ensure a successful outcome. They attempt to define principles of practice for providing appropriate care. The principles are not inclusive of all proper methods of care nor exclusive of other methods reasonably directed at obtaining the same results.
The ultimate decision regarding the appropriateness of any treatment must be made by each healthcare provider considering the circumstances of the individual situation and in accordance with the laws of the jurisdiction in which the care is rendered.
The Doctor’s Advocate is published quarterly by Corporate Communications, The Doctors Company. Letters and articles, to be edited and published at the editor’s discretion, are welcome. The views expressed are those of the letter writer and do not necessarily reflect the opinion or official policy of The Doctors Company. Please sign your letters, and address them to the editor.